Rasan Stock (8313): Price, GoFinsa Rating and News
GoFinsa provides a guide to Rasan stock, listed under ticker 8313, explaining its economic sector and factors that may help readers assess the stock.
About Rasan and Its Business
Rasan Information Technology develops digital platforms for the insurance and financial services sectors. Its key solutions include Tameeni, a platform for comparing and purchasing insurance products online, as well as technology tools for insurers, banks and brokers, and solutions for portfolio data analysis and pricing. Its activities also include vehicle auction platforms and certain digital brokerage services. Its business is connected to transaction volumes on its platforms and demand for digital transformation in the insurance sector.
Rasan Stock Information
Rasan stock trades on the Saudi Exchange under ticker 8313 and is classified in the insurance sector. Reviewing official disclosures and financial results can help readers understand the company’s position and how its business is developing.
Rasan’s Activities and Company Information
The company is classified in the insurance sector of the Saudi market. Annual reports and official disclosures should be consulted to learn about its activities, revenue sources and operational developments.
The Insurance Sector in the Saudi Economy
The performance of listed insurance companies can be affected by demand for their products and services, operating costs, competition, and economic and regulatory conditions. Each company’s sensitivity to these factors depends on its business model.
How to Read a Stock’s Financial Results
It is important to compare revenue, profit, cash flows and debt across several financial periods and to understand the reasons for changes rather than relying on the result of a single quarter. Official announcements should also be reviewed for information about material events.
Factors That May Affect the Stock Price
Rasan’s share price may be affected by the company’s results and disclosures, trends in the Saudi market, interest rates and investor expectations. A price movement alone does not indicate an improvement in operating performance.
Investment Risks
Potential risks include share-price volatility, changes in costs, weaker demand, competition and regulatory changes. The actual risks vary according to the company’s activities and financial position.
The Stock’s Investment Strength According to the GoFinsa Saudi Stocks Index
The rating recorded for the stock in the GoFinsa GFSI is 59%. This is an independent analytical rating, not a guarantee of profit or a personal recommendation to buy.
Investing in Saudi Stocks
The Saudi Exchange includes companies operating across a range of economic sectors. Investors can benefit from reviewing disclosures, comparing financial valuations, diversifying risk and setting an investment horizon before making a decision.
Following Company News
The latest disclosures and news concerning Rasan stock can be followed through news sources and official information available on GoFinsa. Readers should check the date of each item and how directly it relates to the company.
Saudi Insurance Sector Indicators in 2026
Gross written premiums across the Saudi insurance sector totaled SAR 29.8 billion in the first quarter of 2026, an annual increase of 14.4%. These figures relate to the sector as a whole and are not Rasan’s financial results.
Rasan’s Reference Price
The recorded reference price was SAR 139.7 on 2026-10-08. This is a historical price, not a live quote or a confirmed current trading price.
Rasan’s Rating in the GoFinsa GFSI
The GoFinsa GFSI rating recorded for the stock is 59%. This is a GoFinsa research rating, not a recommendation to buy or sell.
Overview of the Insurance Sector
Rasan stock belongs to the insurance sector on the Saudi Exchange. Companies in the sector are affected by demand, competition, costs, and economic and regulatory conditions, although their risk profiles and revenue sources differ.
Trading Through XTB and Associated Risks
What Does Rasan Do?
Rasan (8313) is classified in the insurance sector. The potential research scope of the company includes insurance or reinsurance services, subject to the company’s licenses and products. Exact details and subsidiary activities should be checked against the company’s latest official profile before publication.
Where Does Rasan’s Revenue Come From?
When assessing Rasan’s business model, review the following income sources where supported by the company’s financial statements: insurance service results and net investment results. The model for reinsurance differs. These items should not be taken to mean that all of them actually contribute to the company’s revenue.
Factors That Affect Rasan’s Performance
Indicators relevant to monitoring Rasan’s activities include premium growth, claims, the combined ratio, reserves and solvency. Trends should be compared across multiple periods using the company’s actual results. Growth or profitability should not be inferred without documented figures.
What to Check in the Annual Disclosure
When reviewing Rasan (8313), first identify the date of the latest annual report, then read its description of actual activities, operating segments and revenue recognition policy. Review the notes to the financial statements rather than relying only on management’s summary; the notes may disclose obligations or events that are not apparent from the headline figures. Confirm the identity of the listed entity, its subsidiaries and the nature of their operations before attributing any activity or project to the company. Trends across the insurance sector should not be treated as evidence of revenue growth at this company unless supported by its published results.
How to Distinguish Genuine Growth from Accounting Changes
To assess Rasan, compare results across several equivalent periods and watch for non-recurring items, reclassifications and changes in the consolidation scope. Higher revenue does not necessarily mean stronger profitability if the cost of sales or expenses have risen faster. Examine the operating and net profit margins, then review management’s notes on the reasons for the changes. If reliable, up-to-date financial statements are unavailable, these remain analytical steps rather than a description of Rasan’s actual performance.
Cash Flows and the Ability to Fund Operations
When reviewing Rasan’s data, it is useful to distinguish accounting profit from cash generated by operations. Examine net operating cash flows, changes in working capital, capital expenditure and financing costs. A company may report a profit while operating cash declines because of increased receivables, inventory or project payments. Conversely, cash flow may be temporarily affected by the timing of collections and payments. The company’s liquidity or solvency cannot be assessed without the relevant financial statements and notes.
Debt and Financing Costs: Key Questions
If Rasan has financing obligations, begin by identifying their maturities, the split between short- and long-term debt, borrowing costs and any contractual covenants. Assess how sensitive profits and cash flows may be to changes in interest rates, taking into account whether financing instruments carry fixed or variable rates. The importance of these questions varies with a company’s business model in the insurance sector. This guide does not assume that the company has any particular level of debt or risk.
Comparing the Stock with Sector Peers Without Misleading Conclusions
For a fair comparison of Rasan stock, select companies with similar activities, revenue mix, scale and regulatory settings. Compare revenue growth, margins, return on capital and cash flows, and then consider differences in accounting and financial leverage. A lower price-to-earnings ratio than that of another company is not, by itself, enough to conclude that the stock is cheaper; the difference may reflect expectations for growth, risk or earnings quality. If a company has losses or non-recurring profits, some valuation multiples may not be suitable for comparison.
How to Read the Reference Price and Its Date
The reference price shown in this guide is historical and dated, not a live bid or ask quote. When assessing Rasan, check which trading session the price relates to and whether capital changes, a share split or dividends affect the historical comparison. Do not confuse the previous closing price with the latest trade or the session’s average price. If market data updates are delayed, its date should be clearly shown, and an old figure should not be used to infer a new daily trend.
Build Scenarios Instead of Predicting a Specific Price
Three scenarios can be used to assess Rasan: improving business conditions, conditions remaining unchanged, and weaker demand or margins. For each scenario, define measurable assumptions such as sales volume, input costs or financing expenses, then compare the results with published financial statements when available. Do not set a target price without a valuation model and documented inputs, and do not present the positive scenario as an expected outcome. This approach is intended to help investors understand how an investment may respond to new information.
Checklist Before Making an Investment Decision
Before dealing in Rasan stock, confirm the ticker 8313, the company’s identity and the price date, and review the latest material disclosure, financial results and auditor’s notes, if any. Distinguish GoFinsa’s research rating from the suitability of an investment for your personal circumstances. Set your investment horizon, assess your tolerance for losses and consider your portfolio’s exposure to the insurance sector. Review broker fees and the type of financial instrument: owning shares directly differs from trading derivatives or contracts for difference, which may involve additional risks.
المصادر والمراجع
أسئلة شائعة عن الشركة
What is Rasan’s stock ticker?
Rasan trades on the Saudi Exchange under ticker 8313.
Which sector does Rasan stock belong to?
The stock is classified in the insurance sector.
Is the GoFinsa rating a recommendation to buy?
No. The rating is an analytical tool; it is not a personal investment recommendation or a guarantee of future performance.